idacio adalimumab

Idacio (adalimumab-aacf) is a prescription medicine indicated for the treatment of multiple conditions, including rheumatoid arthritis, psoriatic arthritis, Crohn’s disease, ulcerative colitis, juvenile idiopathic arthritis, ankylosing spondylitis, and plaque psoriasis¹. Idacio is approved by the FDA in the USA, as well as by the EMA in the EU^2,3.